Johnson & Johnson to end sale of opioids, settles New York case for $230 million

6/26/21–Johnson & Johnson will pay $230 million to resolve an opioids lawsuit, days before the company was slated to go to trial, in a settlement reached with New York Attorney General Letitia James. In the agreement, the company will end the sale of all opioid products nationwide. Read